Literature DB >> 8145899

Inhibition of rat pituitary tumor cell proliferation by benzodiazepines in vitro.

J Kunert-Radek1, H Stepień, M Pawlikowski.   

Abstract

The effect of various benzodiazepines (peripheral-type receptor ligands: Ro 5-4864, PK 11135; central-type receptor ligands: clonazepam, Ro 15-1788, Ro 15-4513; mixed type: diazepam) on the proliferation of estrogen-induced rat pituitary prolactin-secreting tumor cells was studied in vitro. [3H]thymidine incorporation into DNA was used as an index of cell proliferation. It was found that tested peripheral- and mixed-type benzodiazepine receptor ligands significantly suppressed the pituitary cell proliferation in a dose-dependent manner (10(-4)-10(-8) M). The inhibitory effect of Ro 5-4864 was reversed by 5 x 10(-3) M calcium chloride. On the other hand, central-type benzodiazepine receptor ligands suppressed tumor cell proliferation only at the highest concentration studied (10(-4) M). Our results indicate that benzodiazepines might exert an antiproliferative action on pituitary tumor cell growth, and that this effect seems to be a calcium-dependent process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145899     DOI: 10.1159/000126644

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

Review 1.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

2.  Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells.

Authors:  Sutapa Mukhopadhyay; Bobby Guillory; Shyamali Mukherjee; Salil K Das
Journal:  Mol Cell Biochem       Date:  2010-03-04       Impact factor: 3.396

3.  Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells.

Authors:  K Maaser; M Höpfner; A Jansen; G Weisinger; M Gavish; A P Kozikowski; A Weizman; P Carayon; E O Riecken; M Zeitz; H Scherübl
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

4.  Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies.

Authors:  Tao Zhang; Xiaowen Yang; Jianrui Zhou; Pei Liu; Hui Wang; Anrong Li; Yi Zhou
Journal:  Oncotarget       Date:  2017-10-19

5.  Benzodiazepine-Associated Carcinogenesis: Focus on Lorazepam-Associated Cancer Biomarker Changes in Overweight Individuals.

Authors:  Shih-Chieh Ku; Pei-Shen Ho; Yu-Ting Tseng; Ta-Chuan Yeh; Shu-Li Cheng; Chih-Sung Liang
Journal:  Psychiatry Investig       Date:  2018-09-17       Impact factor: 2.505

6.  Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line.

Authors:  Jovana Drljača; Aleksandra Popović; Dragica Bulajić; Nebojša Stilinović; Sašenka Vidičević Novaković; Slobodan Sekulić; Ivan Milenković; Srđan Ninković; Marko Ljubković; Ivan Čapo
Journal:  CNS Neurosci Ther       Date:  2022-06-15       Impact factor: 7.035

7.  Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies.

Authors:  Tzu-Rong Peng; Li-Jou Yang; Ta-Wei Wu; You-Chen Chao
Journal:  Medicina (Kaunas)       Date:  2020-10-01       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.